Clinical Trial Update: A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a pilot phase 1/2 study evaluating ALTENS to improve dysphagia caused by IMRT in head and neck cancer patients; the update …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ALTENS

Snippet

Sponsor: McMaster University | Conditions: Head and Neck Cancer, Dysphagia | Phase 1, Phase 2 | Status: UNKNOWN